-
AstraZeneca won't profit from COVID-19 vaccine in pandemic
Pharmaceutical company AstraZeneca repeated its promise not to profit from a COVID-19 vaccine during the pandemic as it reported it was on track with late-stage trials for the treatment. Such promises were boosted by strong sales across its range of treatments during lockdown. Sales jumped by 14% to $12.6 billion in the first six months of 2020 and were helped by strong trading in new medicines, as well as cancer and respiratory medication. -
Senator urges Ottawa to support Canadian vaccine company awaiting funding
An Alberta senator is urging Ottawa to fund a Canadian company so it can develop a domestic COVID-19 vaccine to lessen the risk Canadians will have wait in a line on a foreign-made pandemic cure. "I really do believe that we need to keep the pressure now on the government of Canada, whom I'm not criticizing. I get that this is an unusual time. And this may be in hand, or it may have fallen through the cracks. But we can't allow that to happen,'' Sen. Doug Black said in an interview Monday.